Condition: Cognitive Behavioral Therapy · Sponsor: University of Pittsburgh
The study includes participants experiencing distress with regard to stopping immunotherapy and will utilize cognitive-behavioral therapy to reduce fear of recurrence, depression, and anxiety and improve quality of life.
This description comes directly from the study's public registry record.
Jennifer L Steel, Ph.D. · 412-692-2041 · steejl@upmc.edu
Jason Luke, MD · 412-623-4511 · lukejj@upmc.edu
Always discuss trial participation with your own doctor first.
| UPMC Hillman Cancer Centers | Pittsburgh, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04761328